Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2018
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN StudyAjay K Gopal, Stephen J Schuster, Nathan H Fowler, et al.
Molecular Cancer Therapeutics|October 21, 2020
Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and <sup>90</sup>Y-DOTAJohnnie J Orozco, Aimee L Kenoyer, Yukang Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2015
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete RemissionAndrew J Cowan, Philip A Stevenson, Ryan D Cassaday, et al.
The New England Journal of Medicine|January 24, 2014
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphomaAjay K Gopal, Brad S Kahl, Sven de Vos, et al.
Blood|March 13, 2023
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphomaRyan C Lynch, Chaitra S Ujjani, Christina Poh, et al.
Journal for Immunotherapy of Cancer|June 29, 2023
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomasAndrew L Coveler, David C Smith, Tycel Phillips, et al.
Blood Cancer Journal|July 8, 2024
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remissionMazyar Shadman, Kwang W Ahn, Manmeet Kaur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and ToxicityCaron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Transplantation and Cellular Therapy|July 7, 2023
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell LymphomaNarendranath Epperla, Ambuj Kumar, Syed A Abutalib, et al.
Pageof 19